On July 8, 2020, the U.S. Food and Drug Administration (“FDA”) delivered the results of its most comprehensive sampling study on the current cannabidiol (“CBD”) marketplace to the U.S. House Committee on Appropriations and...more
Reporting no evidence of residual effects on drivers, last fall’s findings contribute to the growing discussion of cannabis’s effects on consumers. Over the autumn of 2019, a group of researchers out of Toronto announced...more